PRKDC and autoimmune disease: Our study reveals that DNA-PKcs deficiency or missense mutations result in aberrant cGAS activation that leads to overactivation of innate immunity, making cGAS a promising target to treat autoimmune diseases caused by DNA-PKcs deficiency.